Leo F, Mastorino L, Cangialosi L, Favre D, et al. Minimal Disease Activity as A New Therapeutic Target in Atopic Dermatitis: A 5-Year Real-Life Experience With Dupilumab. Int J Dermatol 2026 Jan 13. doi: 10.1111/ijd.70260.
PMID: 41531105